{
    "nctId": "NCT01259076",
    "briefTitle": "Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer",
    "officialTitle": "Effect of Weight Loss on Breast Density Using Both Digital Mammography and Breast MRI",
    "overallStatus": "TERMINATED",
    "conditions": "Healthy, no Evidence of Disease",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 43,
    "primaryOutcomeMeasure": "Change in BMI and breast density",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women eligible for gastric bypass surgery\n* Pre-menopausal women\n* All women will have signed an informed consent form prior to participating in study procedures\n\nExclusion Criteria:\n\n* Women with a history of breast cancer\n* Women currently taking exogenous hormone replacement therapy\n* Women currently taking a SERM\n* Women currently taking an aromatase inhibitor\n* Pregnant or lactating women\n* Women who have been pregnant or lactating in the past 2 years\n* Women who have metallic or other surgical implants\n* All subjects will have a determination of their estimated glomerular filtration rate (eGFR) within 24 hours of undergoing any study where gadolinium based contrast agents will be administered\n* Subjects should not have a known history of recent onset acute renal dysfunction\n* Subjects with a history of stable chronic renal dysfunction may participate in studies using GBCA based on their eGFR, as outlined below\n* Subjects should not have severe liver dysfunction, particularly when associated with kidney disease\n* Subjects should receive GBCAs in the perioperative period (i.e. within 4 weeks) after renal or liver transplantation",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT"
}